SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
11.05
+0.01 (0.09%)
At close: Aug 11, 2026, 4:00 PM EDT
11.06
+0.01 (0.06%)
After-hours: Aug 11, 2026, 7:59 PM EDT
SLS Market Cap
SLS has a market cap or net worth of $2.17 billion as of August 11, 2026. Its market cap has increased by 1,278.67% in one year.
Market Cap
2.17B
Enterprise Value
2.04B
1-Year Change
1,278.67%
Ranking
Category
Stock Price
$11.05
ChartMarket Cap Chart
Since March 12, 2008, SLS's market cap has increased from $133.40M to $2.17B, an increase of 1,528.78%. That is a compound annual growth rate of 16.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.05B | 282.46% |
| Dec 31, 2025 | 537.00M | 633.61% |
| Dec 31, 2024 | 73.20M | 115.29% |
| Dec 29, 2023 | 34.00M | -30.04% |
| Dec 30, 2022 | 48.60M | -44.65% |
| Dec 31, 2021 | 87.80M | 59.64% |
| Dec 31, 2020 | 55.00M | 163.16% |
| Dec 31, 2019 | 20.90M | -22.88% |
| Dec 31, 2018 | 27.10M | 125.83% |
| Dec 29, 2017 | 12.00M | -43.13% |
| Dec 30, 2016 | 21.10M | -91.13% |
| Dec 31, 2015 | 238.00M | 29.77% |
| Dec 31, 2014 | 183.40M | -64.87% |
| Dec 31, 2013 | 522.00M | 404.35% |
| Dec 31, 2012 | 103.50M | 412.38% |
| Dec 30, 2011 | 20.20M | -57.38% |
| Dec 31, 2010 | 47.40M | -36.12% |
| Dec 31, 2009 | 74.20M | -6.31% |
| Dec 31, 2008 | 79.20M | -40.63% |
| Mar 12, 2008 | 133.40M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vericel | 2.27B |
| Nuvation Bio | 2.24B |
| Septerna | 2.23B |
| Palvella Therapeutics | 2.22B |
| ADMA Biologics | 2.22B |
| Mesoblast | 2.21B |
| Biohaven | 2.19B |
| Vera Therapeutics | 2.18B |